Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Peptic Ulcer Disease III: Clinical Manifestations and Complications01:25

Peptic Ulcer Disease III: Clinical Manifestations and Complications

Duodenal UlcersDuodenal ulcers are the most common form of peptic ulcer disease, presenting with chronic, intermittent epigastric pain. Pain typically appears 2–3 hours after meals, especially when the stomach is empty, often waking patients at night. It is characteristically relieved by food or antacids (“pain–food–relief”). Some patients remain asymptomatic until complications like bleeding or perforation emerge, particularly with NSAID or anticoagulant use.Gastric UlcersGastric ulcers share...
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease I: Introduction01:25

Peptic Ulcer Disease I: Introduction

Peptic ulcer disease (PUD) involves breaks in the gastrointestinal tract's mucosal lining, primarily in the stomach and duodenum, with less frequent occurrences in the lower esophagus or near the pylorus.Ulcers can be acute or chronic. Acute ulcers are short-lived with minimal inflammation and heal quickly after the irritant is removed. Chronic ulcers persist, may recur, and often cause scarring due to ongoing tissue damage. Superficial erosions affect only the mucosal layer and are called...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunomodulatory and Antimicrobial Effects of Pd(II)-Pincer-Type Complex.

Biomedicines·2026
Same author

Muscle Function Impairment in Crohn's Disease Patients: Risk Factors and Clinical Implications-Single-Tertiary-Center Experience.

Life (Basel, Switzerland)·2026
Same author

Case Report: Toxocariasis as a rare trigger of vasculitis: a case-based review.

Frontiers in immunology·2026
Same author

Circulating EV miRNA Cargo in Glioblastoma Patients Is Associated with Distinct Gene Expression Signatures in Peripheral Immune Cells, Suggesting an Early, Compartment-Specific Immune Priming State.

Biomedicines·2026
Same author

Neutrophil Extracellular Traps in Exocrine Pancreatic Disease: A Comprehensive Review of Pathogenesis, Severity Stratification, and Therapeutic Targeting.

Cells·2026
Same author

Porous organosilica nanoparticles enable UV blocking and two-photon fluorescence imaging.

Journal of materials chemistry. B·2026

Related Experiment Videos

[Upper gastrointestinal bleeding--five-year experience from one centre].

Ivan Jovanović, Dragan Popović, Srdjan Djuranović

    Srpski Arhiv Za Celokupno Lekarstvo
    |August 30, 2008
    PubMed
    Summary
    This summary is machine-generated.

    Acute upper gastrointestinal bleeding is frequently caused by erosive gastropathy and duodenal ulcers. Nonsteroidal anti-inflammatory drug (NSAID) and salicylate use are common risk factors, particularly for duodenal ulcers.

    Related Experiment Videos

    Area of Science:

    • Gastroenterology
    • Internal Medicine
    • Emergency Medicine

    Context:

    • Acute upper gastrointestinal bleeding is a common medical emergency.
    • Endoscopy is a primary diagnostic tool for identifying bleeding sources.
    • Risk factors for gastrointestinal bleeding require thorough investigation.

    Purpose:

    • To determine the incidence of erosive gastropathy and duodenal ulcers in upper GI bleeding.
    • To analyze the relationship between these conditions and patient demographics (age, gender).
    • To assess the association with known risk factors, such as NSAID and salicylate use.

    Summary:

    • A retrospective analysis of 3,954 emergency upper endoscopies (2000-2005) identified causes of acute upper GI bleeding.
    • Erosive gastropathy and duodenal ulcers accounted for up to 60% of cases.
    • Duodenal ulcers were linked to male gender and NSAID/salicylate abuse; erosive gastropathy showed a weaker association with these factors.

    Impact:

    • Highlights the significant contribution of erosive gastropathy and duodenal ulcers to upper GI bleeding emergencies.
    • Emphasizes the role of NSAIDs and salicylates as key risk factors, especially for duodenal ulcers.
    • Suggests the need for further research into the etiology of erosive gastropathy unrelated to NSAID/salicylate use.